Arena Pharma (ARNA) PT Raised to $63 at Credit Suisse
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Price: $99.98 --0%
Rating Summary:
10 Buy, 13 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 7 | New: 4
Rating Summary:
10 Buy, 13 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 7 | New: 4
Join SI Premium – FREE
Credit Suisse analyst Martin Auster raised the price target on Arena Pharma (NASDAQ: ARNA) to $63.00 (from $61.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Campbell's Co. (CPB) PT Raised to $19 at UBS, Sell Rating Maintained
- FireFly Metals Ltd (FFM:AU) PT Raised to AUD3 at BMO Capital
- BRP Inc. (DOO:CN) (DOOO) PT Raised to Cdn$110 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
